| Date | Title | | | 11/12/09 | Life Technologies Addresses Promise of Cell Therapies at Industry Leader Summit|
Company Hosts Cell Therapy Summit to Discuss Best Practices for
Bringing Therapeutics to Market
CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 12, 2009--
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative
life science solutions, today is hosting the 1st
Annual Cell Therapy Industry Summit, gathering leaders from all
areas of cell therapy to discuss best practices and opportunities for
bringing potential life saving therap... |
|  | | 11/10/09 | Life Technologies Signs Definitive Agreement to Acquire BioTrove|
Acquisition enhances company’s strategic offerings in high growth
PCR market
CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 10, 2009--
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative
life science solutions, today announced that it has signed a definitive
agreement to acquire BioTrove, Inc. for an undisclosed amount.
BioTrove’s primary technology is the OpenArray® platform, a
high throughput gene expression and ge... |
| | | 11/10/09 | University of Cambridge and Life Technologies Collaborate on Landmark High Throughput Sequencing Hub in United Kingdom|
Advanced Genomic Analysis Technology to Support Genomics and
Biomedical Genetics Research
CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 10, 2009--
The University of Cambridge and Life Technologies Corporation
(NASDAQ:LIFE), announced today the formation of a collaboration to
advance translational research studies in key disease areas such as
cancer, diabetes and neurological disorders. Through this collaboration,
next generation sequencing... |
| | | 10/27/09 | Life Technologies Announces Third Quarter 2009 Results|
Third quarter GAAP revenue of $801 million, and non-GAAP revenue
of $805 million
Third quarter GAAP earnings per share of $0.22, and non-GAAP
earnings per share of $0.73
Free cash flow of $164 million in the third quarter
CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 27, 2009--
Life Technologies Corporation (NASDAQ:LIFE) today announced results for
its third quarter ended September 30, 2009. Non-GAAP revenue for the
... |
| | | 10/22/09 | Global Commercialization of Applied Biosystems 3500 Series Genetic Analyzers Sets New Standards for Throughput, Data Quality and Ease-of-Use| CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 22, 2009--
Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE),
today announced the global commercial availability of a new capillary
electrophoresis (CE) sequencing system. The 3500 Series Genetic Analyzer
builds on Applied Biosystems’ industry-leading CE sequencing systems,
with state-of-the-art advancements, setting significant new standards
for throughput, data quality and ease of ... |
| | | 10/21/09 | Life Technologies Delivers Enhanced Next-Generation Genomic Analysis Technology for Large-Scale Resequencing Projects|
SOLiD™ 3 Plus Enables Higher Throughput, Decreased Cost, and Faster
Data Analysis on Life Science Industry’s Most Accurate Sequencing
Platform
CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 21, 2009--
Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE)
today announced the commercial availability of the SOLiD™ 3 Plus System,
an enhanced next-generation genomic analysis platform designed to allow
research... |
| | | 10/14/09 | Life Technologies Announces Appointment of Sales Vice President for Next Generation Sequencing|
Sales Leader to Bring Years of Experience to Key Role within
Commercial Operations
CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 14, 2009--
Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative
life science solutions, today announced that it has named Jay Therrien
to the position of Vice President, Global Sales for Next Generation
Sequencing. In this role, Therrien will be responsible for all sales
activities related to Li... |
| | | 10/13/09 | Applied Biosystems Advances 21st Century Forensics with Innovative DNA Analysis Solutions|
New Generation of Kits Delivers Faster Recovery of More DNA Results
from a Wider Range of Samples
CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 13, 2009--
Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE),
today announced a new generation of forensic DNA kits with chemistry
reagents designed to address the increasing challenges facing 21st
century forensic laboratories. The new AmpFℓSTR® Identifiler®
Direct, Ide... |
| | | 10/06/09 | Baylor College of Medicine Expands Fleet of SOLiD(TM) Systems to Expand Cancer Studies and Other Complex Human Diseases| CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 6, 2009--
Scientists from the Baylor
College of Medicine Human Genome Sequencing Center (HGSC) are
expanding their fleet of advanced genomic next-generation sequencing
technology from Applied Biosystems, part of Life Technologies
Corporation (NASDAQ:LIFE) to accelerate their studies of the genetic
underpinnings of cancer and other complex human diseases. Additional
SOLiD™ Systems will be integrated... |
| | | 10/06/09 | Life Technologies Sets Third Quarter 2009 Earnings Release Date for Tuesday, October 27, 2009| CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 6, 2009--
Life Technologies Corporation (NASDAQ:LIFE) announced today it will
report its third quarter 2009 financial results on Tuesday, October 27,
2009, before market open. The company will also hold a conference call
on the same day at 8:30 a.m. EDT to discuss operating results.
The webcast can be accessed through the investor relations page of the
Life Technologies’ website at www.lifetechn... |
| | | 09/29/09 | Life Technologies Foundation Awards $1.7 Million in Grants to Advance Science|
Seven non-profit organizations to receive grants for research and
education efforts
CARLSBAD, Calif.--(BUSINESS WIRE)--Sep. 29, 2009--
The Life Technologies Foundation, a non-profit arm of Life Technologies
Corporation (NASDAQ: LIFE) dedicated to advancing science education and
scientific discovery, has awarded approximately $1.7 million in new
grants that include the creation of an online biology textbook, and
building a museum exhibi... |
| | | 09/28/09 | Life Technologies and febit Team to Offer New Solution for Targeted Re-sequencing in Large-scale Genomic Studies| febit’s HybSelectTM technology for sequence capture combined with Applied Biosystems’ SOLiD™ System enable automated, high sample throughput next generation sequencing
CARLSBAD, CA. (USA), and HEIDELBERG, Germany, September 28, 2009 – febit holding GmbH and Life Technologies Corporation (NASDAQ: LIFE) today announced that they have entered into a strategic co-marketing agreement to provide a new, scalable solution for researchers conducting targeted re-sequencing studies. In addition, febi... |
| | | 09/22/09 | Agilent Technologies, Life Technologies Co-Market Target-Enrichment System for Next-Generation Sequencing| SANTA CLARA and CARLSBAD, Calif., Sept. 22, 2009 – Agilent Technologies Inc. (NYSE: A) and Applied Biosystems, part of Life Technologies Corp. (NASDAQ: LIFE), today introduced the Agilent SureSelect Target Enrichment System, which is optimized for the SOLiD™ System, a next-generation advanced genomic analysis sequencing platform. As part of the agreement, the companies are co-marketing the SureSelect system, which is a unique research tool for efficiently re-sequencing specific regions of ... |
| | | 09/16/09 | Applied Biosystems Launches New Genomic Analysis Tools that Simplify Disease Research| PCR-based Workflow Cost-effectively Captures Details of Genetic Variation in Biological Samples
CARLSBAD, Calif., Sep 16, 2009 (BUSINESS WIRE) -- Applied Biosystems, part of Life Technologies Corporation
(NASDAQ:LIFE), today announced the launch of genomic analysis tools that
will help researchers in studies that associate genetic variation with
specific diseases. These new tools, known as the MeltDoctor(TM)
High-Resolution Melt (HRM) Reagents, are for research u... |
| | | 09/15/09 | Life Technologies to Present at UBS Global Life Sciences Conference| CARLSBAD, Calif.--(BUSINESS WIRE)--Sep. 15, 2009--
Life Technologies Corporation (NASDAQ: LIFE) today announced it will
present at the UBS Global Life Sciences Conference on September 22 at
8:30 a.m. Eastern Time at the Grand Hyatt Hotel in New York City. Greg
Lucier, Life Technologies’ Chairman and Chief Executive Officer, will be
presenting on behalf of the company. A live webcast of the presentation
will be available on the investor relation... |
| | | 09/09/09 | Life Technologies Named to Dow Jones Sustainability World Index for Second Time| CARLSBAD, Calif.--(BUSINESS WIRE)--Sep. 9, 2009--
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative
life science solutions, today announced it was named a member of the Dow
Jones Sustainability World Index (DJSI World) for the second year in a
row, demonstrating the company’s global leadership in business,
environmental and social issues.
“We’re proud to again be recognized for our achievements in conse... |
| | | 09/02/09 | Life Technologies to Sell Mass Spectrometry Business to Danaher for $450 Million in Cash| CARLSBAD, Calif.--(BUSINESS WIRE)--Sep. 2, 2009--
Life Technologies Corporation (NASDAQ:LIFE) today announced it has
signed a definitive agreement to sell its ownership stake in its mass
spectrometry business, operated as a joint venture, to Danaher
Corporation (NYSE:DHR) for $450 million in cash. Danaher has also signed
an agreement to acquire Life Technologies’ joint venture partner in the
mass spectrometry business, MDS Analytical Technologi... |
| | | 08/10/09 | Life Technologies Completes Divestiture of Laboratory Information Management Software Business| CARLSBAD, Calif.--(BUSINESS WIRE)--Aug. 10, 2009--
Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative
life science solutions, today announced that it has completed the
previously announced sale of its SQL*LIMS® business to
LabVantage Solutions, Inc. for an undisclosed amount.
The SQL*LIMS® business is an enterprise laboratory
information management system (LIMS) provider that manages the
laboratory process lifecyc... |
| | | 07/30/09 | Invitrogen Launches Biomarker Tool for Pre-Clinical Research into Kidney Function| CARLSBAD, Calif.--(BUSINESS WIRE)--Jul. 30, 2009--
Invitrogen, part of Life Technologies Corporation (NASDAQ:LIFE), today
announced the global availability of a new biomarker tool for use in
pre-clinical research into kidney function. The PlexMark™ 3 Renal
Biomarker Panel Assay is a non-invasive and cost-effective research tool
for performing kidney function post-transplantation studies rapidly and
easily. The introduction of this research tool... |
| | | 07/28/09 | University of Queensland and Life Technologies Collaborate on Landmark Cancer Research Studies in Australia| CARLSBAD, Calif.--(BUSINESS WIRE)--Jul. 28, 2009--
The University of Queensland’s Institute for Molecular Bioscience (IMB)
and Life Technologies Corporation (NASDAQ:LIFE), today announced a
strategic scientific research collaboration to study pancreatic and
ovarian cancer in Australia. This landmark study involves the genomic
analysis of pancreatic and ovarian tumors, using advanced sequencing
technology from Applied Biosystems, part of Life Te... |
| | | 07/28/09 | Life Technologies Announces Second Quarter 2009 Results and $200 Million of Debt Repayment| Second quarter GAAP revenue of $833 million, and non-GAAP revenue of $839 million
Second quarter GAAP earnings per share of $0.22, and non-GAAP earnings per share of $0.79
Free cash flow of $105 million in the second quarter
CARLSBAD, Calif.--(BUSINESS WIRE)--Jul. 28, 2009--
Life Technologies Corporation (NASDAQ: LIFE) today announced results for
its second quarter ended June 30, 2009. Non-GAAP revenues for the first
quarter were $839 million, an increase of 2 pe... |
| | | 07/21/09 | Applied Biosystems and Chromsystems Team Up to Simplify Mass Spectrometry for Clinical Research| CARLSBAD, Calif. and MUNICH, Germany, July 21, 2009 – Applied Biosystems, part of Life Technologies Corporation (NASDAQ: LIFE), and Chromsystems Instruments & Chemicals GmbH today announced joint solutions for the clinical research field. These solutions provide complete, integrated workflows to simplify mass spectrometry technology for a variety of clinical research applications, such as therapeutic drug monitoring.
These solutions are expected to accelerate the adoption of new tests,... |
| | | 07/10/09 | Life Technologies Releases Global Citizenship Report| CARLSBAD, Calif., Jul 10, 2009 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative
life science solutions, announced today the release of its 2008 Global
Citizenship Report.
The report provides an update on Life Technologies' philanthropic
endeavors, ethical policies and environmental sustainability efforts in
2008, which are an integral part of Life Technologies' overall mission
to shape biological discovery and ultim... |
| | | 07/08/09 | Invitrogen Presents Latest Trends in Stem Cell Technologies at ISSCR Meeting| Tutorials Provide Insight into Pioneering Approaches to Culture and Expansion of Multiple Human Cell Types
Carlsbad, Calif., July 8, 2009 – Invitrogen, part of Life Technologies Corporation (NASDAQ: LIFE), will present major trends in stem cell technologies this week at the International Society for Stem Cell Research (ISSCR) 7th Annual Meeting in Barcelona, Spain. The ISSCR meeting is the pre-eminent international stem cell conference, attracting more than 2,500 of the foremost stem cel... |
| | | 07/08/09 | Applied Biosystems Unveils New Real-Time PCR Assays That Quantify Proteins in Human Cells| CARLSBAD, Calif.--(BUSINESS WIRE)--Jul. 8, 2009--
Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE),
today announced the introduction of a new line of TaqMan®
real-time PCR assays that enable researchers to rapidly detect and
quantify proteins in human cell samples. The TaqMan Protein Expression
Assays enable researchers to correlate relative levels of specific
proteins with cell functions and behaviors, such as different diseas... |
| | | 07/07/09 | Invitrogen Launches Life Science Industry's First Complete Resource for Cellular Technologies and Education| CARLSBAD, Calif.--(BUSINESS WIRE)--Jul. 7, 2009--
Invitrogen, part of Life Technologies Corporation (NASDAQ:LIFE), today
announced the launch of the life-science industry’s first comprehensive
online resource for cell biology information and technology. The
Invitrogen Cell
Resource Center is a Web portal that brings together educational
resources and the latest technologies for advancing cellular research.
This Web-based hub enables scie... |
| | | 07/02/09 | Life Technologies Sets 2nd Quarter 2009 Earnings Release Date for Tuesday, July 28, 2009| CARLSBAD, Calif.--(BUSINESS WIRE)--Jul. 2, 2009--
Life Technologies Corporation (NASDAQ: LIFE) announced today it will
report its second quarter 2009 financial results on Tuesday, July 28,
2009, after market close. The company will also hold a conference call
on the same day at 4:30 p.m. EDT to discuss operating results.
The webcast can be accessed through the investor relations page of the
Life Technologies’ website at www.lifetechnologies.c... |
| | | 07/01/09 | Applied Biosystems Partners With China to Help Reinforce New Standards for Food Safety| CARLSBAD, Calif. & BEIJING--(BUSINESS WIRE)--Jul. 1, 2009--
Applied Biosystems, part of Life Technologies Corporation (NASDAQ:
LIFE), today announced that it is assisting the Chinese government in
reinforcing new standards for food safety in China. As part of its
effort to enhance its ability to monitor the domestic food supply in
addition to global exports, the Chinese General Administration of
Quality Supervision, Inspection and Quarantine (CIQ... |
| | | 06/30/09 | Applied Biosystems Salmonella Detection Kit Assists Efforts to Protect Food Supply| Molecular Testing Solution Receives Emergency Response Validation for Detection of Salmonella in Peanut Butter
CARLSBAD, Calif.--(BUSINESS WIRE)--Jun. 30, 2009--
Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE),
today announced the certification of its TaqMan® Salmonella
enterica Detection Kit for the identification of Salmonella
in peanut butter through the new Emergency Response Validation program
of the AOAC
Research Instit... |
| | | 06/30/09 | Life Technologies to Divest Laboratory Information Management Software Business| CARLSBAD, Calif.--(BUSINESS WIRE)--Jun. 30, 2009--
Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative
life science solutions, today announced that it has signed a definitive
agreement to sell its SQL*LIMS business to LabVantage Solutions, Inc.
for an undisclosed amount.
Under the terms of the agreement, LabVantage will continue to support
the SQL*LIMS product and customers will receive the same level of
support to w... |
| | | 06/29/09 | Invitrogen Launches New Microarray System to Simplify Immunogenetic Testing| Prodigy System Advances Process for HLA in Stem Cell and Solid Organ Transplant Research
CARLSBAD, Calif.--(BUSINESS WIRE)--Jun. 29, 2009--
Invitrogen, part of Life Technologies Corporation (NASDAQ:LIFE), today
announced the commercial availability of a state-of-the-art, automated,
research-use microarray system designed to simplify immunogenetic
testing, including human leukocyte antigen (HLA) research. The new
Prodigy™ system is an advanced DNA and prote... |
| | | 06/22/09 | Applied Biosystems Launches Sequencing-based Solution to Advance Whole Transcriptome Research| New SOLiD Kit Provides Comprehensive, Quantitative Analysis of RNA Present in Biological Samples
CARLSBAD, Calif.--(BUSINESS WIRE)--Jun. 22, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced the launch of a new sequencing-based
genomics tool to advance the analysis of whole transcriptomes. The
SOLiD™ Whole Transcriptome Analysis Kit is the latest addition to a
leading suite of reagents, optimized for use ... |
| | | 06/16/09 | Video Interview: Gregory T. Lucier, CEO and Chairman, Life Technologies| NASDAQ CEO Signature Series Broadcasted From the NASDAQ MarketSite NEW YORK, Jun 16, 2009 (GlobeNewswire via COMTEX) -- Veteran business journalist Joya Dass joins Gregory T. Lucier, CEO and Chairman, Life Technologies (LIFE) to discuss the company's industry, strategy, financials and positioning.
Click here to view video: http://investor.shareholder.com/ceosignature/webcast.cfm?mediaid=37440&k=5351AB8114C0178A366A40AFA3A5C403
Gregory T. Lucier serves as Chief Executive Officer of Li... |
| | | 06/12/09 | Life Technologies Foundation Announces $2 Million in Grants to Advance Science| CARLSBAD, Calif.--(BUSINESS WIRE)--Jun. 12, 2009--
The Life Technologies Foundation today announced that it has awarded $2
million to three grant recipients working to advance science, including
the University of North Texas for DNA-PROKIDS, the New York Academy of
Sciences and the Science Museum in London.
Funding efforts as varied as preventing human trafficking in developing
counties, training doctors on new technologies and helping the ... |
| | | 06/10/09 | Life Technologies Foundation Sponsors BioBlitz Educational Programs in New York City| BioBlitzing in the Boroughs Shows Biodiversity and Environmental Awareness Through the Power of Science
CARLSBAD, Calif.--(BUSINESS WIRE)--Jun. 10, 2009--
The Life Technologies Foundation today announced its award of $50,000 to
the E.O. Wilson Foundation for the sponsorship of a series of BioBlitz
educational programs that will coincide with the World Science
Festival®, occurring June 10-14 in New York City.
During a BioBlitz, professional naturali... |
| | | 06/02/09 | French Researchers Accelerate Biomarker Research With QTRAP(R) 5500 Mass Spectrometry Systems| CARLSBAD, Calif.--(BUSINESS WIRE)--Jun. 2, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced that scientists at bioMérieux, a world
leader in the field of in vitro diagnostics, and the Institute of
Analytical Sciences of the University of Lyon in France are
collaborating on research to advance the discovery of biomarkers that
can be used to diagnose or monitor disease. They are using
next-gen... |
| | | 06/02/09 | Applied Biosystems Expands Portfolio of Services to Support Mass Spectrometry Workflows| CARLSBAD, Calif.--(BUSINESS WIRE)--Jun. 2, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced a set of new services offered through its
Global Services organization to better support its mass spectrometry
customers. The new services include: compliance services for regulated
laboratories to simplify and facilitate deployment of AB
SCIEX 5500 systems; an expanded Web-based solution for remote
m... |
| | | 06/01/09 | Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometry Tools to Advance Public Health and Safety| CARLSBAD, Calif.--(BUSINESS WIRE)--Jun. 1, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDS
Analytical Technologies, a business unit of MDS Inc. (TSX:MDS)
(NYSE:MDZ), today announced the commercial availability of new mass
spectrometry tools to help laboratories in a variety of industries
advance their efforts to improve public health and safety. The Cliquid®
... |
| | | 06/01/09 | Applied Biosystems/MDS Analytical Technologies Accelerates Productivity for Drug Development and Clinical Research With New Mass Spectrometry Solution| CARLSBAD, Calif.--(BUSINESS WIRE)--Jun. 1, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDS
Analytical Technologies, a business unit of MDS Inc. (TSX:MDS)
(NYSE:MDZ), today announced the launch of Cliquid® MPX™-2
high-throughput workflow, an end-to-end solution for mass spectrometry
users to accelerate productivity for pharmaceutical and clinical
re... |
| | | 05/26/09 | Applied Biosystems Introduces Two New Lines of Capillary Electrophoresis Genetic Analyzers| CARLSBAD, Calif.--(BUSINESS WIRE)--May. 26, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced the expansion of its industry-leading
portfolio of capillary electrophoresis sequencing systems with the
introduction of two new lines of genetic analyzers. The 3500 Series, for
research use only, will be available worldwide. The 3500 Dx Series is
intended for clinical use and will initially be launched in ... |
| | | 05/21/09 | Invitrogen Scientists Compile Comprehensive Guidebooks for Stem Cell Research| CARLSBAD, Calif.--(BUSINESS WIRE)--May. 21, 2009--
Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE),
today announced that four of its scientists whose work is focused in
stem cell research are editors of two recently published books that
capture many of the latest findings in this field and provide
comprehensive guidelines for applying technologies to advance related
applications. Emerging Technology Platforms for Stem Cells, by
... |
| | | 05/20/09 | Applied Biosystems Introduces New Real-time PCR Solution to Quantitate Host Cell DNA Impurities in Biopharmaceutical Manufacturing| CARLSBAD, Calif.--(BUSINESS WIRE)--May. 20, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced the launch of the life science industry’s
first integrated real-time PCR solution for measuring residual DNA
impurities from Chinese
Hamster Ovary (CHO) host cells. The new solution significantly
enhances the ability of biopharmaceutical companies to rapidly and
accurately quantitate the impuri... |
| | | 05/20/09 | Invitrogen Launches Enriched Online Retail Experience for Its Award-Winning Website| CARLSBAD, Calif.--(BUSINESS WIRE)--May. 20, 2009--
Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE),
today announced significant enhancements to its online store: www.invitrogen.com.
These improvements simplify product selection and ordering, and further
streamline laboratory workflows for users of the site, which is the
top-rated online source for life science products.
The new features are part of a series of improvem... |
| | | 05/19/09 | Applied Biosystems DNA Analysis Technology Aids Cheetah Conservation Program| CARLSBAD, Calif.--(BUSINESS WIRE)--May. 19, 2009--
A new high-tech DNA laboratory is the latest tool in the international
effort to save the endangered cheetah population. The Applied Biosystems
Genetic Conservation Laboratory, located at the headquarters of the
Cheetah Conservation Fund (CCF) in Otjiwarongo, Namibia, is the result
of a collaboration between CCF and Applied Biosystems, a division of
Life Technologies Corporation (NASDAQ:LIFE). Throug... |
| | | 05/18/09 | Life Technologies Announces Presentations at 2009 BIO International Convention| CARLSBAD, Calif.--(BUSINESS WIRE)--May. 18, 2009--
Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative
life science solutions, will be engaging partners, customers and
industry peers in thought-provoking dialogue on major trends and
opportunities, including the $1,000 genome and induced pluripotent stem
cells during the 2009 BIO International Convention from May 18-21 at the
Georgia World Congress Center in Atlanta.
... |
| | | 05/14/09 | Life Technologies Licenses Quantum Dots Technology to Zymera for Imaging and Biomarker Discovery Applications| Agreement Broadens use of Qdot Nanocrystals to Enhance In Vivo imaging and Biomarker Discovery
CARLSBAD, Calif.--(BUSINESS WIRE)--May. 14, 2009--
Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative
life science solutions, and Zymera, Inc., today announced a licensing
and supply agreement that gives Zymera rights to Life Technologies’
extensive intellectual property estate related to quantum
dots. Zymera will use Life Technologies’ Qdot®
... |
| | | 05/13/09 | Life Technologies Employees Lend a Hand During Sixth Annual Global Volunteer Day| Employees Volunteer More Than 12,000 Hours for Local Communities
CARLSBAD, Calif.--(BUSINESS WIRE)--May. 13, 2009--
Nearly 3,000 employees at Life Technologies Corporation (NASDAQ: LIFE),
a provider of innovative life science solutions, today are donating a
half day of their time to more than a hundred projects around the globe.
It’s part of the company's sixth Annual Global Volunteer Day, the first
since Invitrogen merged with Applied Biosystems in Novemb... |
| | | 05/05/09 | Life Technologies Equipping Laboratories Around the World to Help Accelerate Detection of Influenza A (H1N1)| Company Working Directly with U.S. Centers for Disease Control, Association of Public Health Laboratories and International Agencies
CARLSBAD, Calif.--(BUSINESS WIRE)--May. 5, 2009--
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative
life science solutions, today announced that it is helping to accelerate
detection of Influenza A (H1N1) by providing instrument systems and
other components to public health laboratories across the United States,
... |
| | | 05/05/09 | Scientists from Applied Biosystems First to Sequence Entire Human Genome in Single Run at 17-fold Coverage| SOLiD(TM) 3 System Enables Generation of 50 Gigabases of Sequence Data from Human Disease Sample Provided by Baylor College of Medicine
CARLSBAD, Calif.--(BUSINESS WIRE)--May. 5, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE) today announced that its research and development
scientists used human disease samples from the Baylor College of
Medicine Human Genome Sequencing Center to sequence an entire human
genome in a s... |
| | | 05/04/09 | Invitrogen Develops New Technology to Promote Safer Stem Cell Therapies|
CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen, a division of Life Technologies (NASDAQ:LIFE - News), today
announced a new technology to enable the development of safer stem cell
therapies. Dynabeads® SSEA-4, addresses a key challenge in translational
research by separating undifferentiated stem cells from those that are
differentiated. Scientists from Invitrogen and the Buck
Institute for Age Research, located in Novato, Calif., collaborated
i... |
| | | 05/04/09 | Applied Biosystems Launches Molecular Tools for Measuring Gene Activity in Biological Pathways| New TaqMan Array Plates Enable Systems Biology Approach to Gene Expression Analysis
CARLSBAD, Calif.--(BUSINESS WIRE)--May. 4, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today introduced a new set of molecular tools for
investigating the role of specific genes involved in more than 80 key
biological pathways. The
TaqMan®
Array Gene Signature Plates enable scientists to cost-effectively
measure the ac... |
| | | 04/30/09 | Life Technologies Supports Laboratories in Battle Against Swine Flu| Company Provides Instruments, Reagents and Related Components to Support Laboratories' Efforts in Flu Detection and Nucleic Acid Sequencing
CARLSBAD, Calif.--(BUSINESS WIRE)--Apr. 30, 2009--
Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative
life science solutions, today announced that it is providing its
technologies to health officials across the globe to aid in the
identification of influenza strains, particularly the strain associated
... |
| | | 04/30/09 | Life Technologies to Present at Three Financial Conferences in May 2009| CARLSBAD, Calif.--(BUSINESS WIRE)--Apr. 30, 2009--
Life Technologies Corporation (NASDAQ: LIFE) announced today it will
present at three upcoming financial conferences.
Greg Lucier, Chairman and Chief Executive Officer of Life Technologies,
will present at the Baird’s 2009 Growth Stock Conference on Thursday,
May 14, at 12:15 p.m. EDT in Chicago, IL.
David Hoffmeister, Chief Financial Officer at Life Technologies, will
present ... |
| | | 04/29/09 | Applied Biosystems Launches New Tools to Increase Food Safety through Detection of Salmonella and Listeria monocytogenes| CARLSBAD, Calif.--(BUSINESS WIRE)--Apr. 29, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced the expansion of its portfolio of food
safety testing solutions with new kits and software to improve the
detection of Salmonella
and Listeria
monocytogenes in food. These new tools, which include MicroSEQ®
Pathogen Detection kits, PrepSEQ™ sample preparation kits and
data analysis softw... |
| | | 04/28/09 | Applied Biosystems and Geospiza Team Up to Offer Next-Generation Genetic Analysis on Amazon Web Services| New Solution to Ease Bioinformatics Challenges Associated With Ultra High-Throughput Sequencing
CARLSBAD, Calif.--(BUSINESS WIRE)--Apr. 28, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), and Geospiza, Inc. today announced the launch of a
next-generation genetic analysis solution to meet the computational
infrastructure and analysis challenges of customers using advanced
genomic analysis platforms. The organizations ar... |
| | | 04/28/09 | Life Technologies Announces First Quarter 2009 Results| First quarter GAAP revenue of $776 million, and non-GAAP revenue of $785 million
CARLSBAD, Calif.--(BUSINESS WIRE)--Apr. 28, 2009--
Life Technologies Corporation (NASDAQ: LIFE) today announced results for
its first quarter ended March 31, 2009. Non-GAAP revenues for the first
quarter were $785 million, an increase of 1 percent over first quarter
revenues of $775 million in 2008, as if Invitrogen and Applied
Biosystems had been combined. Excluding the negat... |
| | | 04/21/09 | Applied Biosystems Scientists Use Next-Generation Sequencing to Associate Methylation Patterns with the Development of Cancer| CARLSBAD, Calif., Apr 21, 2009 (BUSINESS WIRE) -- Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today unveiled new approaches for using next-generation
genomic analysis sequencing to better understand methylation patterns in
different cancerous disease states. A team of research and development
scientists utilized the SOLiD(TM) System, an advanced genomic analysis
technology, to characterize the methylation status of repeti... |
| | | 04/13/09 | Invitrogen Launches Next-Generation Cell Culture Solution for Immunology Research| CARLSBAD, Calif.--(BUSINESS WIRE)--Apr. 13, 2009--
Invitrogen, a division of Life Technologies (NASDAQ:LIFE), today
announced the launch of GIBCO® OpTmizer™
T-cell Expansion SFM, a next-generation solution for culturing and
expanding human T-cells that does not require the addition of serum to
achieve optimal, cost-efficient results. OpTmizer SFM will enable
scientists to advance their research on the central role that T-cells
play in hu... |
| | | 04/09/09 | New Genomics Tools from Applied Biosystems Broaden Applications of RNA Expression Analysis| Expanded Coverage of Species Aids Disease Research and Agricultural Studies
CARLSBAD, Calif., Apr 09, 2009 (BUSINESS WIRE) -- Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced the release of a new set of genomic
analysis tools to aid disease research and agricultural studies. These
tools are available through the latest release of the TaqMan(R)
Gene Expression Assays product line to evaluate levels of RNA
expre... |
| | | 04/08/09 | Scientists Use Advanced Genomic Technology from Applied Biosystems to Uncover Profiles of Gene Activity from Single Cells| Published Research in Nature Methods Details the Detection of 75% More Expressed Genes Than Microarray Approaches
CARLSBAD, Calif., Apr 08, 2009 (BUSINESS WIRE) -- Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE) today announced that researchers have discovered
comprehensive profiles of gene activity from single cells using the
SOLiD(TM) System, its next-generation genomic analysis platform. The
finding, which is detailed in the curre... |
| | | 04/07/09 | Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometer to Accelerate Proteomics Research| AB SCIEX 5800 System Sets New Standard to Translate Biomarker Discovery Into Applications for Personalized Medicine
CARLSBAD, Calif., Apr 07, 2009 (BUSINESS WIRE) -- Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), and
its mass spectrometry joint-venture partner, MDS Analytical
Technologies, a business unit of MDS Inc. (TSX:MDS) (NYSE:MDZ), today
introduced the AB
SCIEX TOF/TOF(TM)
5800 System, the fastest, most sensitive MALDI-based mas... |
| | | 04/07/09 | Life Technologies Sets 1st Quarter 2009 Earnings Release Date for Tuesday, April 28, 2009| CARLSBAD, Calif., Apr 07, 2009 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE) announced today it will
report its first quarter 2009 financial results on Tuesday, April 28,
2009, after market close. The company will also hold a conference call
on the same day at 4:30 p.m. EDT to discuss the results, as well as
future expectations.
The webcast can be accessed through the investor relations page of the
Life Technologies' website at www.lifete... |
| | | 04/06/09 | Life Technologies' Innovative Online Annual Report Now Available| CARLSBAD, Calif., Apr 06, 2009 (BUSINESS WIRE) -- Building on the success of the award-winning 2007 Life Technologies
(formerly Invitrogen) Online Annual Report, Life Technologies
Corporation announced today that its 2008 Online Annual Report is
available at www.lifetechnologies.com.
The annual report is available through Life Technologies' online news
gallery, which houses informational videos and highlights from the
company and gives media easy access t... |
| | | 04/01/09 | Invitrogen Introduces Innovation that Speeds Regulatory Filings and Time to Market for Biotherapeutics Manufacturers| New Protein Expression Kit Enables Serum-free, Stable Cell Line Development under cGMP Guidelines
CARLSBAD, Calif.--(BUSINESS WIRE)--Apr. 1, 2009--
Invitrogen, a division of Life Technologies (NASDAQ:LIFE), today
announced the launch of the GIBCO®
OptiCHO™ Protein Express Kit, a new integrated solution for
simple and efficient development of serum-free, stable cell lines for
biotherapeutic development. This is the first kit of its kind to provide
ce... |
| | | 03/24/09 | Invitrogen Launches Benchtop Device That Simplifies Primary and Stem Cell Research| CARLSBAD, Calif.--(BUSINESS WIRE)--Mar. 24, 2009--
Invitrogen, a division of Life Technologies (NASDAQ:LIFE), today
announced the launch of the Neon
Transfection Device, a bench-top tool that enables researchers to
better understand the functions of cells, genes and proteins. This
device simplifies the delivery of DNA, RNA, and proteins into a wide
range of mammalian cell types, especially difficult to transfect cells,
such as many types of pr... |
| | | 03/23/09 | Life Technologies and Nanosys Introduce Anti-Counterfeiting Solutions| CARLSBAD, Calif. & SAN FRANCISCO--(BUSINESS WIRE)--Mar. 23, 2009--
Life Technologies Corporation (NASDAQ: LIFE), and Nanosys, Inc. today
announced a cross-licensing agreement to share rights to an intellectual
property estate related to fluorescent nanocrystals (also known as
quantum dots). New products developed as a result of this agreement will
help prevent counterfeiting worldwide. The quantum dots will allow
manufacturers to trace the source... |
| | | 03/18/09 | Life Technologies Receives Frost & Sullivan 2009 North American Drug Discovery Technologies Company of the Year Award| Gregory T. Lucier Named 2009 North American Drug Discovery Technologies CEO of the Year
CARLSBAD, Calif.--(BUSINESS WIRE)--Mar. 18, 2009--
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative
life science solutions, announced today that it has been named 2009
North American Drug Discovery Technologies Company of the Year by Frost
& Sullivan. In addition, the company's Chairman and Chief
Executive Officer, Greg Lucier, was named 2009 North ... |
| | | 03/18/09 | Applied Biosystems/MDS Analytical Technologies AB SCIEX QTRAP 5500 Mass Spectrometry System Earns Scientists' Choice Award from SelectScience| CARLSBAD, Calif.--(BUSINESS WIRE)--Mar. 18, 2009--
Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), and
its mass spectrometry joint-venture partner, MDS Analytical
Technologies, a business unit of MDS Inc. (TSX:MDS) (NYSE:MDZ), today
announced that the
AB SCIEX QTRAP®
5500 System, a unique, next-generation mass spectrometer, has
received the Scientists’ Choice Award for Best New Spectroscopy Product
by SelectScience.ne... |
| | | 03/16/09 | Life Technologies to Webcast Investor Presentation as Part of The UBS West Coast Bus Tour| CARLSBAD, Calif.--(BUSINESS WIRE)--Mar. 16, 2009--
Life Technologies Corporation (NASDAQ:LIFE) today announced it will be
webcasting senior management presentations to investors as part of the
UBS West Coast Life Sciences Bus Tour on Monday, March 23, 2009, at 8:00
a.m. PDT at the company’s headquarters in Carlsbad. Presenters will
include Greg Lucier, Life Technologies’ Chairman and Chief Executive
Officer; Mark Stevenson, the company’s President an... |
| | | 03/16/09 | Life Technologies Named to FTSE4Good Index Series| CARLSBAD, Calif.--(BUSINESS WIRE)--Mar. 16, 2009--
Life Technologies Corporation (NASDAQ:LIFE) announced today that it has
been named to the FTSE4Good Index Series, an equity index series that is
designed to facilitate investment in companies that meet globally
recognized citizenship standards. Companies in the FTSE4Good Index
Series have met stringent social, ethical and environmental criteria.
“As the leading life science tools comp... |
| | | 03/11/09 | Applied Biosystems Launches New TaqMan(R) Genotyping Assays to Identify a Leading Form of Structural Variation in the Human Genome| CARLSBAD, Calif., Mar 11, 2009 (BUSINESS WIRE) -- Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced the introduction of a new line of
genotyping assays that enable researchers to more closely study the
significant role that DNA copy number structural variation plays in
human health and disease. The TaqMan(R)
Copy Number Assays are designed to detect and quantify copy number
variations (CNVs), which are o... |
| | | 03/10/09 | Applied Biosystems/MDS Analytical Technologies Launch New Test Methods to Simplify Mass Spectrometry Applications| New iMethods enhance food and environmental testing, forensic toxicology and clinical research
CARLSBAD, Calif.--(BUSINESS WIRE)--Mar. 10, 2009--
Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), and
its mass spectrometry joint-venture partner, MDS Analytical
Technologies, a business unit of MDS Inc. (TSX:MDS)(NYSE:MDZ), today
announced the commercial availability of a new suite of test methods
that simplify the use of mass spectrometry te... |
| | | 03/10/09 | Everglades Environmental Restoration Project Aided by Mass Spectrometry Solution From Applied Biosystems/MDS Analytical Technologies| CARLSBAD, Calif.--(BUSINESS WIRE)--Mar. 10, 2009--
Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), today
announced that scientists at Jupiter Environmental Laboratories in
Florida are using a mass spectrometry solution to support the
environmental restoration of the once pristine waterways of the Florida
Everglades. These scientists are using this technology as part of their
support of the Comprehensive
Everglades Restoratio... |
| | | 03/09/09 | Translational Genomics Research Institute and Applied Biosystems Accelerate Use of Genomics Research for Medical Applications| Enhanced Understanding of Genetic Basis of Disease to Hasten Advent of Personalized Medicine
CARLSBAD, Calif.--(BUSINESS WIRE)--Mar. 9, 2009--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), and the Translational
Genomics Research Institute today announced a strategic alliance
designed to accelerate research into complex diseases and medical
conditions. As part of this alliance, a team of scientists from TGen and
Appli... |
| | | 03/03/09 | Life Technologies to Present at the Cowen and Company 29th Annual Health Care Conference| CARLSBAD, Calif.--(BUSINESS WIRE)--Mar. 3, 2009--
Life Technologies Corporation (NASDAQ: LIFE) today announced it will
present at the Cowen and Company 29th Annual Health Care
Conference on Tuesday, March 17, at 8:00 a.m. EDT at the Boston Marriott
Copley Place. Mark Stevenson, Life Technologies’ President and Chief
Operating Officer, will present on behalf of the company. The
presentation will be followed by a 35-minute breakout session at 8:45
... |
| | | 02/26/09 | Invitrogen Earns AmeriStar Award for GIBCO Cell Culture Bottle Design| Innovative, Ergonomic Packaging Promotes Ease of Use, Storage Efficiency, and Reduced Sample Contamination
CARLSBAD, Calif.--(BUSINESS WIRE)--Feb. 26, 2009--
Invitrogen, a division of Life Technologies (NASDAQ:LIFE), today
announced that it has received the prestigious AmeriStar® Package Award
from the Institute of Packaging Professionals for its new GIBCO®
cell culture bottle. Invitrogen launched the redesigned GIBCO bottle
in October of last year to offe... |
| | | 02/19/09 | Forensic DNA Shown to Lower Crime Rates and Decrease Property Loss| Law Enforcement Agencies Utilize Technologies From Applied Biosystems to Improve Investigations of Non-Violent Crimes
CARLSBAD, Calif.--(BUSINESS WIRE)--Feb. 19, 2009--
Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), today
announced that its forensic DNA solutions are successfully being used
for a broader range of criminal investigations that include non-violent
crimes, such as burglaries, auto thefts and other property crimes. These
tec... |
| | | 02/16/09 | Applied Biosystems and Baylor College of Medicine Summarize Contributions to First Data Release of 1000 Genomes Project| SOLiD System Generates More Than 400 Gigabases of Mappable Sequence Data for Project
CARLSBAD, Calif.--(BUSINESS WIRE)--Feb. 16, 2009--
Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), and
scientists from the Baylor College of Medicine Human Genome Sequencing
Center (HGSC), today summarized their collective contribution to the
first data release of the 1000 Genomes Project. As a commercial
participant and as part of Applied Biosystems’ co... |
| | | 02/12/09 | Life Technologies Announces Fourth Quarter and Fiscal Year 2008 Results| GAAP revenue of $541 million in fourth quarter and $1.6 billion for full year
CARLSBAD, Calif.--(BUSINESS WIRE)--Feb. 12, 2009--
Life Technologies Corporation (NASDAQ: LIFE) today announced results for
its fourth quarter and full year ended December 31, 2008. Non-GAAP
revenues for the fourth quarter were $545 million, including $4 million
of non-GAAP revenue adjustments, resulting in full year non-GAAP
revenues of $1,625 million, an increase of 27 percent ... |
| | | 02/05/09 | Applied Biosystems Awards Genomic Research Grant to St. Jude Children's Research Hospital| Researchers Will Use SOLiD 3 System to Conduct Whole Genome Re-sequencing to Detect Genetic Alterations in Acute Lymphoblastic Leukemia
CARLSBAD, Calif.--(BUSINESS WIRE)--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced the recipient of its “What Would You Do
With a $10K Genome” grant program. This program was created to inspire
new scientific approaches that employ advanced genomic technologies that
are now e... |
| | | 02/05/09 | Applied Biosystems Collaborates With Leading Medical Institution to Study Mechanisms of Cancer Development Using SOLiD System| Researchers Describe Sequencing-Based Approach for Associating Large Genomic Rearrangements With Cancer-Specific RNA Expression Profiles
CARLSBAD, Calif.--(BUSINESS WIRE)--
A team of researchers from the Mayo
Clinic today announced preliminary data that demonstrates the
advantages of sequencing-based approaches for associating structural
variants with RNA expression profiles to identify potential biomarkers
in head and neck cancer. The data is the result o... |
| | | 02/04/09 | Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System| Technologies from Applied Biosystems and Invitrogen Create Comprehensive Solutions for Advanced Genomic Analysis; Platform Unmatched for Combination of Throughput and Accuracy
CARLSBAD, Calif.--(BUSINESS WIRE)--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced that it will begin shipment of a new,
genomic analysis platform, the SOLiD™
3 System, February 14. The new system delivers a roadmap that will
ultimately... |
| | | 02/02/09 | Life Technologies Highlights 2008 Philanthropy and Provides Focus for Grant Giving in 2009| CARLSBAD, Calif.--(BUSINESS WIRE)--
Life Technologies (NASDAQ:LIFE), a provider of innovative life science
solutions, announced today that it donated more than $500,000 in funding
to a dozen programs through its Life Technologies™ Foundation (formerly
the Invitrogen Foundation) in 2008.
In 2008, the Life Technologies™ Foundation was created to support
science education and advance society’s understanding of the importance
of scientific... |
| | | 01/29/09 | University of Texas at Austin Acquires SOLiD System to Advance Genomic Research| New Laboratory Will Facilitate Research for Targeted Resequencing and Transcriptome Analysis Applications
CARLSBAD, Calif.--(BUSINESS WIRE)--
Applied Biosystems, a division of Life Technologies Corporation
(NASDAQ:LIFE), today announced that the University
of Texas at Austin has chosen the SOLiD™
System for next-generation genomic analysis to further push the
boundaries of research as part of its new Genome Sequencing and Analysis
Facility. Scientis... |
| | | 01/27/09 | Life Technologies Wins Verdict on its SOLiD(TM) Sequencing System| CARLSBAD, Calif., Jan 27, 2009 (BUSINESS WIRE) -- (NASDAQ:LIFE) announced today that a jury in the U.S. District Court for
the Northern District of California rendered a verdict in its favor in
its patent-infringement dispute with Illumina, Inc.
In this dispute, Illumina alleged that the SOLiD(TM) sequencing system
commercialized by Applied Biosystems, a subsidiary of Life Technologies,
infringed three patents, namely U.S. Patent Nos. 5,969,119; 5,750,341;
... |
| | | 01/22/09 | Life Technologies Sets 4th Quarter and Full Year 2008 Earnings Release Date for Thursday, February 12, 2009| CARLSBAD, Calif.--(BUSINESS WIRE)--Jan. 22, 2009--Life Technologies Corporation (NASDAQ:LIFE) announced today it will
report its fourth quarter and full year 2008 financial results on
Thursday, February 12, 2009, before market open. The company will also
hold a conference call on the same day at 9:00 a.m. EST to discuss the
results, as well as future expectations.
The webcast can be accessed through the investor relations page of the
Life Tec... |
| | | 01/21/09 | Invitrogen Launches Benchtop Device That Simplifies Protein Analysis Workflows| BenchPro(TM) 4100 Western Processing Tool Automates Routine Steps for Standard Laboratory Procedures
CARLSBAD, Calif.--(BUSINESS WIRE)--Jan. 21, 2009--Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE),
today announced the introduction of the BenchPro(TM) 4100 Western
Processing Device, a bench-top tool developed to automate processing of
routine washing and incubation steps for standard laboratory procedures.
This device simplifies protein ana... |
| | | 01/13/09 | Invitrogen Launches Xenogeneic-Free Media for Human Embryonic Stem Cell Culture| CARLSBAD, Calif.--(BUSINESS WIRE)--Jan. 13, 2009--Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE),
announced today that it has launched KNOCKOUT(TM) SR XenoFree Media for use
in the culture of human embryonic stem cells (hESCs).
Until now, most of the research carried out on hESCs has used
mouse-derived feeder cells and culture media containing components
derived from bovine sources. Ideally, hESCs research and its translation
... |
| | | 01/13/09 | Invitrogen Receives Approval from Health Canada for System to Help Determine Organ Transplant Compatibility| CARLSBAD, Calif.--(BUSINESS WIRE)--Jan. 13, 2009--Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE),
today announced that its DynaChip(R) HLA Antibody Analysis
System has received approval from Health Canada's Medical Device Bureau
for the detection and identification of antibodies to human leukocyte
antigen (HLA) markers, which is an essential step in determining the
compatibility of organ donors.
HLA markers are proteins... |
| |
|
